2001
DOI: 10.1248/bpb.24.767
|View full text |Cite
|
Sign up to set email alerts
|

Relationship between the Neuroprotective Effect of Na<SUP>+</SUP>/H<SUP>+</SUP> Exchanger Inhibitor SM-20220 and the Timing of Its Administration in a Transient Middle Cerebral Artery Occlusion Model of Rats

Abstract: The aim of this study was to determine the relationship between the neuroprotective effect of SM-20220 (N-(aminoiminomethyl)-1-methyl-1H-indole-2-carboxamide methanesulfonate) and the timing of its administration in an experimental stroke model. Two hours of occlusion followed by 22 h of perfusion of the left middle cerebral artery (MCA) was performed by inserting a nylon thread into the MCA to occlude it, and pulling the thread to initiate reperfusion. Intravenous infusion of SM-20220 for 1 h reduced the infa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2004
2004
2013
2013

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 36 publications
0
4
0
Order By: Relevance
“…It is difficult to view our results in the context of other published data, because the techniques, models, administration regimens, and results reported in the literature are highly diverse, as are the mechanisms of action of the tested drugs. Such compounds as ZK200775 (Turski et al, 1998), YM872 (Takahashi et al, 1998), NXY-059 (Sydserff et al, 2002), FK506 (Furuichi et al, 2003), or SM-20220 (Horikawa et al, 2001) attenuate different mechanisms in the pathogenesis of stroke and exhibit therapeutic windows of 2 to 4 hours in either the pMCA-O or tMCA-O model, but were not evaluated in the SDH model. However, when administered as a continuous intravenous infusion, repinotan is the only compound that displays a therapeutic window of at least 5 hours in all models.…”
Section: Discussionmentioning
confidence: 99%
“…It is difficult to view our results in the context of other published data, because the techniques, models, administration regimens, and results reported in the literature are highly diverse, as are the mechanisms of action of the tested drugs. Such compounds as ZK200775 (Turski et al, 1998), YM872 (Takahashi et al, 1998), NXY-059 (Sydserff et al, 2002), FK506 (Furuichi et al, 2003), or SM-20220 (Horikawa et al, 2001) attenuate different mechanisms in the pathogenesis of stroke and exhibit therapeutic windows of 2 to 4 hours in either the pMCA-O or tMCA-O model, but were not evaluated in the SDH model. However, when administered as a continuous intravenous infusion, repinotan is the only compound that displays a therapeutic window of at least 5 hours in all models.…”
Section: Discussionmentioning
confidence: 99%
“…The NHE inhibitor SM-20220 reduces cerebral endothelial dysfunction after 1–7 days of reperfusion following MCAO in the rat [82, 83]. Edema and neutrophil invasion of the area of ischemic injury are reduced by SM-20220 as well [84].…”
Section: Targetsmentioning
confidence: 99%
“…There is a detectable difference in pH between astrocytic and neuronal compartments, pH being about 0.1 units higher in astrocytes (Kintner et al, 2000), and astrocytes may protect neurons against glutamate toxicity by acidification of the extraneuronal milieu (Ransom, 2000) via the operation of an inwardly directed Na + /HCO 3 cotransporter (Lascola and Kraig, 1997) with a 1:2 stoichiometric ratio for Na + and bicarbonate (McAlear and Bevensee, 2004). In response to intracellular acidity there is also an increased activity of the Na + /H + exchanger, an ubiquitous transporter exchanging intracellular H + with extracellular Na + , and inhibition of Na + /H + exchange reduces infarct size, when applied within 1 h after the onset of the occlusion (Kuribayashi et al, 1999; Horikawa et al, 2001a, b; Kitayama et al, 2001). Strict management of pH during the first hour after reperfusion also has a beneficial effect (Kollmar et al, 2002a).…”
Section: Bioenergetics Of Ischemia In Intact Brain Tissues: Acute Phasementioning
confidence: 99%